81 related articles for article (PubMed ID: 7138083)
1. Fate and excretion of sodium sulisatin in the rat.
Moretó M; Goñalons E; Giráldez A; Torralba A
Arch Farmacol Toxicol; 1982 Apr; 8(1):21-8. PubMed ID: 7138083
[No Abstract] [Full Text] [Related]
2. 3,3-Bis-(4-hydroxyphenyl)-7-methyl-2-indolinone (BHMI), the active metabolite of the laxative sulisatin.
Moretó M; Goñalons E; Mylonakis N; Giráldez A; Torralba A
Arzneimittelforschung; 1979; 29(10):1561-4. PubMed ID: 583222
[TBL] [Abstract][Full Text] [Related]
3. Enterohepatic circulation of sodium sulisatin and its effects on glucose absorption in the rat.
Moretó M; Goñalons E; Mylonakis N; Giräldez A; Torralba A
J Pharm Pharmacol; 1977 Jul; 29(7):446-8. PubMed ID: 19589
[No Abstract] [Full Text] [Related]
4. [Pharmacokinetics and metabolism of sodium picosulfate in the rat (author's transl)].
Jauch R; Hammer R; Busch U; Kopitar Z; Ohnuma N; Niki T
Arzneimittelforschung; 1977; 27(5):1045-50. PubMed ID: 577869
[No Abstract] [Full Text] [Related]
5. Metabolic fate of a new beta2-adrenergic stimulant procaterol (OPC-2009). Absorption, distribution, metabolism and excretion in the beagle dog.
Yasuda Y; Fujisawa N; Morita S; Kohri H
Arzneimittelforschung; 1979; 29(2):261-5. PubMed ID: 36107
[No Abstract] [Full Text] [Related]
6. Distribution and metabolic fate of morphethylbutyne in rats (2-phenoxy-isobutyric acid, 2-morpholine-ethyl ester).
Marchetti E; Bergesi G
Arch Int Pharmacodyn Ther; 1970 Apr; 184(2):245-51. PubMed ID: 5453229
[No Abstract] [Full Text] [Related]
7. [Absorption, distribution and excretion of 14C-fusaric acid in rat (author's transl)].
Matsuzaki M; Matsumoto H; Ochiai K; Tashiro Y; Hino M
Jpn J Antibiot; 1976 May; 29(5):456-66. PubMed ID: 933336
[No Abstract] [Full Text] [Related]
8. Pharmacokinetics and metabolism of anthraquinone laxatives.
Breimer DD; Baars AJ
Pharmacology; 1976; 14 Suppl 1():30-47. PubMed ID: 790405
[No Abstract] [Full Text] [Related]
9. Absorption, distribution, metabolism, and excretion of N,N-diethyl-M-toluamide in the rat.
Schoenig GP; Hartnagel RE; Osimitz TG; Llanso S
Drug Metab Dispos; 1996 Feb; 24(2):156-63. PubMed ID: 8742226
[TBL] [Abstract][Full Text] [Related]
10. Absorption, distribution, metabolism and excretion of YM466, a novel factor Xa inhibitor, in rats.
Mano Y; Sonoda T; Nakamura E; Usui T; Kamimura H
Biopharm Drug Dispos; 2004 Sep; 25(6):253-60. PubMed ID: 15334624
[TBL] [Abstract][Full Text] [Related]
11. Disposition and metabolism of the new hypocholesterolemic compound S-8921 in rats and dogs.
Yamaguchi T; Nakajima Y; Mizobuchi M; Inazawa K; Kanazu T; Kadono K; Ohkawa T; Iwatani K
Arzneimittelforschung; 1998 Oct; 48(10):995-1006. PubMed ID: 9825117
[TBL] [Abstract][Full Text] [Related]
12. Laxatives and the production of kinins by rat colon.
Autore G; Mascolo N; Capasso F
Acta Physiol Hung; 1990; 75 Suppl():17-8. PubMed ID: 2371853
[No Abstract] [Full Text] [Related]
13. Metabolism of drugs. 73. The metabolic fate of nitrofuran derivatives. 1. Studies on the absorption and excretion.
Tatsumi K; Ou T; Yoshimura H; Tsukamoto H
Chem Pharm Bull (Tokyo); 1971 Feb; 19(2):330-4. PubMed ID: 5549057
[No Abstract] [Full Text] [Related]
14. [Comparative study on the physiological disposition of 3H-indirubin and its derivatives, 3H-79002 and 3H-79005, in animals].
Li CL; Ji XJ
Yao Xue Xue Bao; 1983 May; 18(5):332-8. PubMed ID: 6637484
[No Abstract] [Full Text] [Related]
15. Absorption and excretion of piperazine theophylline ethanoate- 14 C in the rat.
Strolin-Benedetti M; Larue DA; Oliver C; Bouvet P
Arzneimittelforschung; 1971 May; 21(5):662-4. PubMed ID: 5109691
[No Abstract] [Full Text] [Related]
16. Absorption, distribution and excretion of [carbonyl-14C]mosapride citrate after a single oral administration in rats, dogs and monkeys.
Matsumoto S; Tagawa M; Amejima H; Nakao M; Kagemoto A; Fujii T; Miyazaki H; Sekine Y
Arzneimittelforschung; 1993 Oct; 43(10):1084-94. PubMed ID: 8267675
[TBL] [Abstract][Full Text] [Related]
17. [Studies on absorption, biotransformation and excretion of drug. VIII. Metabolic fate of a new analgesic and anti-inflammatory agent, 2-oxo-3-[4-(1-oxo-2-isoindolinyl)phenyl]-butanamide (OIB) in rats].
Kigasawa K; Hiiragi M; Maruyama K; Tanaka M; Ohsawa Y; Hayashi T
Yakugaku Zasshi; 1982 Sep; 102(9):866-73. PubMed ID: 6984068
[No Abstract] [Full Text] [Related]
18. Biliary excretion of cobalt in rats.
Cikrt M; Tichý M
J Hyg Epidemiol Microbiol Immunol; 1981; 25(4):364-8. PubMed ID: 7320501
[TBL] [Abstract][Full Text] [Related]
19. [Distribution and excretion of iodamide-380 determined by roentgen fluorescence analysis].
Zajcik VE; Amosov IS; Frolova EI; Jakovlev VJa
Radiol Diagn (Berl); 1983; 24(3):429-34. PubMed ID: 6611913
[No Abstract] [Full Text] [Related]
20. Pharmacokinetic aspect of tritium-labeled glycosaminoglycans (mesoglycan). Their absorption in rat and monkey and tissue distribution in rat.
Zanolo G; Giachetti C; Mascellani G; Magliocca R; Ferrari G
Boll Chim Farm; 1984 May; 123(5):223-35. PubMed ID: 6487425
[No Abstract] [Full Text] [Related]
[Next] [New Search]
